The company will integrate the oligonucleotide manufacturer with two of its existing sections to form a new Nucleic Acid Chemistry business unit.
The arrangement will allow Illumina to market and promote Kailos' research solutions for pharmacogenetic target enrichment.
The certification enables the reagent maker to create optimizing products for use beyond the research market.
Roche said the acquisition will strengthen its next-generation sequencing product offerings.
The partners will combine the sciFlexarrayer with Anteo's reagents to improve the functionality and shelf-life of activated glass and polymer slides and other arrays.
The reagent supplier now has three Japanese distributors following a 2013 deal with GeneDesign as a representative throughout that country.
Sigma-Aldrich will take over distribution of Roche's Biochemical Reagents product portfolio so Roche can focus on other areas of its business.
Qiagen said that Enzymatics' portfolio of reagents are estimated to be used in more than 80 percent of all global NGS sequencing reactions.
The shift back toward therapeutics marks a return to the company's initial focus, which it put on hold last year due to a challenging funding environment.
NEW YORK (GenomeWeb News) — Biofortuna said today that it has received 510(k) clearance from the US Food and Drug Administration for its SSPGo HLA PCR kits.
The president of France's National Research Agency has resigned, according to Nature News.
A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.
The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.
In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.